Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is craniopharyngioma?
Craniopharyngioma is a rare tumor that grows near the base of the brain, close to the pituitary gland, the optic nerves, and the hypothalamus — a small but vital area that controls hormones, growth, appetite, and the body's internal balance. Although craniopharyngioma is not cancer in the usual sense (it does not spread to other parts of the body), it behaves like a serious problem because of its location: as it grows, it can press on the optic nerves and harm vision, disrupt the pituitary gland and cause hormone problems, and block the flow of cerebrospinal fluid and raise pressure in the head. It occurs in two peaks — in children and again in older adults — and can contain a mix of solid tumor and fluid-filled cysts that can enlarge. Symptoms often include headaches, vision changes, slowed growth or delayed puberty in children, excessive thirst and urination, and fatigue from hormone deficiencies. Because the tumor sits among such delicate and important structures, the central challenge of treatment is to control it while protecting vision, hormones, memory, and quality of life. Trying to remove every last bit of tumor can sometimes cause more harm than the tumor itself, so modern care often pairs a more limited surgery with precise radiation. The team typically includes neurosurgeons, radiation oncologists, and endocrinologists who manage hormone replacement, with long-term follow-up because the tumor can recur years later.
The main types
Doctors group craniopharyngioma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Adamantinomatous craniopharyngioma | The more common type, seen especially in children; often has fluid-filled cysts and calcium deposits and tends to stick to nearby structures, making complete removal difficult. |
| Papillary craniopharyngioma | Seen mainly in adults; usually more solid and sometimes driven by a specific gene change (BRAF) that may make it responsive to targeted medicines. |
Staging, in plain terms
Because craniopharyngioma is not a cancer that spreads through the body, it is not given a TNM stage. Instead, doctors describe it by the features that matter for treatment and quality of life. The first is its size and exact location, and how closely it wraps around or presses on the optic nerves, the pituitary gland, and the hypothalamus — the structures responsible for vision and hormones. The second is whether it is mostly solid or contains fluid-filled cysts, because large cysts can be drained and their growth must be watched. The third is its effect on function: whether it is already harming vision, causing hormone deficiencies, or blocking the flow of cerebrospinal fluid and raising pressure. Doctors also consider the patient's age, since protecting the developing brain and hormonal system is especially important in children. These factors, rather than a stage number, determine whether treatment leans toward surgery, radiation, cyst drainage, or a combination, and how aggressively to pursue removal versus protect surrounding structures.
| No formal stage — assessed by size, location, cysts, and effect on vision and hormones | What it generally means |
|---|---|
| Newly diagnosed, limited | A tumor causing few problems that may be removed surgically or, when near critical structures, treated with limited surgery plus precise radiation to protect vision and hormones. |
| Involving critical structures | A tumor wrapped around the optic nerves, pituitary, or hypothalamus, where complete removal risks harm; often best controlled with a more conservative surgery and focused radiation. |
| Cystic or recurrent | A tumor with enlarging cysts or one that has come back after earlier treatment; managed with cyst drainage, repeat surgery, or radiation, sometimes with targeted therapy for papillary tumors. |
The standard of care
Craniopharyngioma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery
An operation removes or reduces the tumor and relieves pressure on the optic nerves and brain; surgeons aim to remove as much as is safe without damaging vision or the hormone-controlling structures.
Radiation therapy
Precise radiation controls tumor that remains after surgery or that cannot be safely removed, and is a mainstay for preventing regrowth while protecting nearby vision and hormone structures.
Cyst management
Fluid-filled cysts can be drained or treated through a small catheter to relieve pressure and shrink the tumor, sometimes before or alongside radiation.
Hormone replacement
Because the tumor and its treatment can affect the pituitary gland, endocrinologists replace missing hormones — such as thyroid, cortisol, growth, and others — to keep the body balanced and healthy.
Targeted therapy for papillary tumors
Papillary craniopharyngiomas driven by a BRAF gene change can respond to targeted medicines, an option being used and studied to shrink these tumors.
How radiation treatment works
Radiation therapy uses focused high-energy beams to damage the DNA inside tumor cells so they can no longer grow and divide. Although craniopharyngioma is not a cancer that spreads, it sits in one of the most delicate neighborhoods in the body — surrounded by the optic nerves that carry vision, the pituitary gland and hypothalamus that control hormones, and the pathways of memory. This is exactly why radiation is so valuable here. Trying to surgically remove every last piece of a craniopharyngioma that is stuck to these structures can cause lasting harm to vision, hormones, or memory. Modern radiation offers a gentler path: after a limited surgery removes the bulk of the tumor and relieves pressure, precise radiation controls whatever remains, dramatically lowering the chance of regrowth while protecting surrounding tissue. The dose is usually given in small daily treatments over several weeks (fractionation), which allows healthy structures like the optic nerves to tolerate it well, and it is shaped tightly around the target using intensity-modulated radiation, stereotactic techniques, or proton therapy. Protons are especially useful in children because the beam stops at a set depth, sparing the rest of the developing brain. One thing the team watches closely during radiation is the tumor's cysts, which can enlarge during treatment and may need to be drained so the radiation stays accurate. With careful planning, radiation achieves excellent long-term control of craniopharyngioma while preserving vision and quality of life as much as possible. Your radiation oncologist works alongside neurosurgeons and endocrinologists to balance tumor control with protection of these vital functions.
The main ways radiation is delivered for craniopharyngioma:
Intensity-modulated / fractionated radiation
Delivers radiation in small daily doses shaped tightly around the tumor over several weeks, controlling it while keeping the dose to the optic nerves, pituitary, and hypothalamus within safe limits.
Stereotactic radiosurgery
Delivers a high, precise dose in one or a few sessions to small, well-defined tumors set safely away from the optic nerves, a focused option for selected cases or recurrences.
Proton therapy
Proton beams stop at a controlled depth, sparing healthy brain beyond the tumor — particularly valuable in children to protect memory, thinking, and growth.
Intracystic treatment
For large cysts, a small catheter can drain the fluid or deliver treatment directly into the cyst, relieving pressure and reducing the tumor before or alongside external radiation.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Limited surgery plus radiation protects function: Studies found that combining a more conservative surgery with precise radiation controls craniopharyngioma as well as aggressive surgery while better preserving vision, hormones, and quality of life, shifting practice away from attempting complete removal in risky locations.[1]
Craniopharyngioma surgery-plus-radiation series
Proton therapy limits dose to the developing brain: Research in children showed that proton radiation achieves high tumor control while sparing healthy brain tissue, helping protect memory, learning, and growth compared with conventional radiation.[2]
Pediatric proton craniopharyngioma studies
BRAF-targeted therapy for papillary tumors: Trials demonstrated that papillary craniopharyngiomas carrying a BRAF gene change can shrink dramatically with targeted medicines, offering a non-surgical option for selected patients.[3]
BRAF inhibitor craniopharyngioma trials
Common questions
If craniopharyngioma isn't cancer, why is it treated so seriously? Even though it does not spread through the body, craniopharyngioma grows in a critical area next to the optic nerves, pituitary gland, and hypothalamus. As it grows it can damage vision, disrupt hormones, and raise pressure in the head, so controlling it is important to protect these vital functions.
Why not just remove the whole tumor with surgery? Craniopharyngiomas often stick to delicate structures that control vision and hormones. Trying to remove every last piece can cause more harm than the tumor itself. Modern care often pairs a more limited surgery with precise radiation, which controls the tumor while better protecting vision, hormones, and memory.
Will I need hormone treatment after radiation? Possibly. Because the tumor and its treatment can affect the pituitary gland, some people need hormone replacement — for example thyroid, cortisol, or growth hormone. An endocrinologist monitors hormone levels and replaces what the body needs to keep you healthy and balanced.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.